Beyond Appetite: Discovering Hidden Opportunities in the GLP-1 Era In just a few short years, GLP-1 receptor agonists have transformed from specialized diabetes medications to household names
Altrient Liposomal Glutathione 450mg + Phosphatidylcholine
Preferential iron trafficking characterizes glioblastoma stem-like cells
Several GPs that showed significant fold changes in subjects with metabolic syndrome had also shown similar changes (e.g., increase or decrease) at the end of 4th week during 30-day intermittent fasting (KIT, CROCC, DNTT, POLK, SRGN, CLSTN1) and 1 week after 30-day intermittent fasting (PRKCSH, CALU, SPECC1L, IGFBP4, MYH7, CDH6, H2B histone, PKP1, LRRC3, FGB, ENPP2) in our previous study conducted in healthy subjects although they had not reached statistical significance 15
Statistical analyses Statistical analyses were performed using GraphPad Prism software (version 9.4.1)
Patients seeking GLP-1-based therapy have several evidence-based options available through prescription from licensed healthcare providers